ARK Investment Management - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$314,575,638
-19.0%
9,948,629
+4.4%
2.41%
-6.4%
Q2 2023$388,467,484
+6.0%
9,525,931
-3.2%
2.57%
+2.1%
Q1 2023$366,631,177
+11.5%
9,837,166
+4.4%
2.52%
-11.5%
Q4 2022$328,691,084
-39.2%
9,420,782
-2.4%
2.85%
-24.4%
Q3 2022$540,409,000
+23.1%
9,657,052
+1.5%
3.77%
+45.1%
Q2 2022$439,003,000
-32.7%
9,514,580
+5.9%
2.60%
-4.7%
Q1 2022$652,651,000
-30.3%
8,981,029
+13.4%
2.72%
-3.7%
Q4 2021$936,092,000
+3.5%
7,916,882
+17.4%
2.83%
+30.3%
Q3 2021$904,648,000
-27.3%
6,743,556
-12.2%
2.17%
-6.2%
Q2 2021$1,244,188,000
+61.3%
7,684,441
-20.1%
2.32%
+51.1%
Q1 2021$771,404,000
+26.7%
9,611,911
-14.1%
1.53%
-5.4%
Q4 2020$608,827,000
+168.5%
11,191,670
-1.9%
1.62%
+20.4%
Q3 2020$226,726,000
-5.4%
11,404,752
+0.0%
1.34%
-47.8%
Q2 2020$239,699,000
+91.4%
11,403,379
+11.4%
2.58%
-17.4%
Q1 2020$125,226,000
-2.3%
10,239,286
+17.1%
3.12%
-3.5%
Q4 2019$128,237,000
+13.4%
8,741,432
+3.2%
3.23%
+31.0%
Q3 2019$113,082,000
-16.2%
8,470,576
+2.8%
2.47%
-27.4%
Q2 2019$134,941,000
-1.0%
8,243,165
+3.3%
3.40%
-12.7%
Q1 2019$136,319,000
+46.8%
7,981,198
+17.3%
3.90%
+3.3%
Q4 2018$92,847,000
-43.6%
6,801,952
+18.2%
3.77%
-24.2%
Q3 2018$164,673,000
+33.3%
5,753,790
+27.5%
4.98%
+10.0%
Q2 2018$123,492,000
+62.5%
4,513,584
+25.3%
4.52%
+19.9%
Q1 2018$75,987,000
+187.5%
3,602,976
+162.0%
3.77%
+79.2%
Q4 2017$26,430,000
+844.9%
1,375,149
+686.7%
2.10%
+286.2%
Q2 2017$2,797,000
+148.6%
174,810
+118.9%
0.54%
+68.2%
Q1 2017$1,125,000
+223.3%
79,850
+200.8%
0.32%
+155.1%
Q4 2016$348,00026,5440.13%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders